Patent · US Active

Anti-CD3 antibodies and methods of use

US10865251B2 · kind B2 · utility

1Cited by
30References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2018
Grant dateDec 15, 2020
Priority date—
Expiry dateSep 27, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.